Power your clinical decisions or research with precision genomics kitted solutions that enable personalized cancer care for all.
Partner with PGDx to access proven thought leadership, regulatory expertise, and proprietary tools to advance your oncology drug development pipeline.
We create clarity for patients and their clinicians by removing barriers to precision oncology testing to make timely, personalized treatments a reality for all.
From idea to innovation
Our comprehensive and flexible testing portfolio of central lab services and kitted assays ensure access to critical biomarker insights on a global scale.
Our comprehensive solid tumor profiling platform for both tissue and plasma samples, backed by standardized bioinformatics, ensures you have access to the critical biomarker insights you need.
Our flexible testing portfolio of central lab services and kitted assays helps you reach patient cohorts around the globe and can accommodate large-scale retrospective studies.
Labcorp is the largest central laboratory in the world, providing global genomics capabilities and expanded capacity and ability to scale
Robust inhouse CRO with global capabilities that enable enrollment of diverse patient groups
Kitted solutions that are easy to implement and use in any geography
We are committed to providing tailored solutions that advance your research, from early access to emerging and complex biomarkers to custom data outputs.
Access to innovative technology that is not yet available within our decentralized kitted solutions
Nimble collaboration, including custom data reporting capabilities and raw data to fuel independent biomarker analysis, custom assay support, and clinical trial assay support
Have the capabilities and infrastructure to implement any technology that will serve our partners
See how we expedite biomarker-driven drug development from discovery to global CDx commercialization.
See how we can help accelerate your path to CDx commercialization.